Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

Off-Label Promotion Ruling Increases Pressure For FDA Policy Change

17 August 2015
The Pink Sheet (subscription required)
Litigation & Dispute Resolution partner Mark Mansour (Washington DC) is quoted in this article discussing how Amarin’s court-approved disclosures could serve as a model that would allow manufacturers to discuss data while also giving FDA input and oversight.

Related Information

  • Related People
    Mark Mansour
    T +1 202 263 3093
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.